Raiffeisen Bank International AG Purchases 627 Shares of Intuitive Surgical, Inc. $ISRG

Raiffeisen Bank International AG lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.0% during the 2nd quarter, HoldingsChannel reports. The fund owned 62,473 shares of the medical equipment provider’s stock after acquiring an additional 627 shares during the quarter. Raiffeisen Bank International AG’s holdings in Intuitive Surgical were worth $32,588,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of ISRG. Tobam raised its position in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 40 shares in the last quarter. Princeton Global Asset Management LLC bought a new position in Intuitive Surgical during the 2nd quarter worth $30,000. TD Capital Management LLC raised its holdings in Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 45 shares in the last quarter. 1248 Management LLC bought a new stake in shares of Intuitive Surgical during the 1st quarter valued at $30,000. Finally, Bank of Jackson Hole Trust grew its holdings in shares of Intuitive Surgical by 70.5% during the 1st quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock worth $37,000 after purchasing an additional 31 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $549.51 on Monday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The company has a market cap of $196.99 billion, a price-to-earnings ratio of 72.69, a PEG ratio of 4.94 and a beta of 1.62. The firm has a 50 day simple moving average of $482.51 and a 200 day simple moving average of $503.01.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the prior year, the business earned $1.84 earnings per share. The company’s revenue for the quarter was up 22.9% compared to the same quarter last year. As a group, analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other news, insider Gary S. Guthart sold 29,360 shares of the company’s stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO David J. Rosa sold 24,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the sale, the chief executive officer owned 234,256 shares in the company, valued at approximately $128,266,872.80. This represents a 9.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 116,164 shares of company stock valued at $61,916,172. 0.70% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

ISRG has been the subject of a number of analyst reports. Robert W. Baird set a $655.00 price target on Intuitive Surgical in a research note on Wednesday, October 22nd. Rothschild & Co Redburn boosted their target price on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Royal Bank Of Canada set a $625.00 price target on shares of Intuitive Surgical and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, October 31st. Finally, Argus upped their target price on Intuitive Surgical from $600.00 to $630.00 in a research note on Monday, October 27th. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $608.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.